<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Shahed University</PublisherName>
				<JournalTitle>Journal of Basic and Clinical Pathophysiology</JournalTitle>
				<Issn>2322-1895</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>10</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Curcumin Alleviates Streptozotocin-Induced Hyperalgesia in Diabetic Neuropathic Rat via Attenuation of Lipid Peroxidation and Inflammation</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>13</FirstPage>
			<LastPage>18</LastPage>
			<ELocationID EIdType="pii">226</ELocationID>
			
<ELocationID EIdType="doi">10.22070/jbcp.2015.226</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Jamshid</FirstName>
					<LastName>Narenjkar</LastName>
<Affiliation>Department of Pharmacology, School of Medicine, Shahed University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Zeinab</FirstName>
					<LastName>Abyar</LastName>
<Affiliation>School of Medicine, Shahed University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mehrdad</FirstName>
					<LastName>Roghani</LastName>
<Affiliation>Neurophysiology Research Center, Shahed University, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>07</Month>
					<Day>11</Day>
				</PubDate>
			</History>
		<Abstract>Background and Objective: Hyperalgesia is one of the marked clinical signs of patients with diabetes mellitus that affects their lifestyle. This study was conducted to assess the anti-nociceptive effect of chronic administration of curcumin in streptozotocin (STZ)-diabetic rats using formalin, hot tail immersion, and paw pressure tests. &lt;br /&gt;Materials and Methods: This study was conducted on 40 male rats that were divided into control, curcumin-treated control, diabetic, and curcumin-treated diabetic groups. The treatment groups received i.p. administration of curcumin at a dose of 50 mg/kg for 4 weeks. Finally, hyperalgesia were assessed using standard tests. Meanwhile, serum MDA and TNFa level was also measured. &lt;br /&gt;Results: Curcumin treatment of diabetic rats significantly reduced pain score in chronic phase of formalin test (pConclusion: Chronic administration of curcumin has anti-nociceptive property, partly via attenuation of lipid peroxidation and inflammatory processes.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Curcumin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Diabetes mellitus</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Anti-nociceptive</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Formalin test</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hot tail immersion test</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Paw pressure test</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lipid peroxidation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Inflammation</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jbcp.shahed.ac.ir/article_226_bd1ededd585cb22c790fffde293bb498.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
